Publication | Closed Access

2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: Synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies

Molecular Docking StudiesMedicinal ChemistryAnti-inflammatoryBioorganic ChemistryAntiparasitic AgentMedicineNatural SciencesImmunologyPharmacological AgentDrug DevelopmentPharmacologyDrug Discovery